Advertising and Marketing within the Pharmaceutical industry: Navigating ethical and regulatory-demanding situations
Complementary and Alternative Medicine
A Review on Rotavirus Infection
Proactive Drug Information Training for Pharmacy Students in a Teaching Hospital
A Review Based on the Synthesis of Isoniazid Derivatives and their Pharmacological Activities
Proactive Drug Information Training for Pharmacy Students in a Teaching Hospital
A Review on Rotavirus Infection
A Review Based on the Synthesis of Isoniazid Derivatives and their Pharmacological Activities
Overview and Role of Pharmacist in the Management of Peutz-Jeghers Syndrome: Clinical Understanding, Management Approaches and Epidemiological Perspectives
Complementary and Alternative Medicine
Pharmaceutical marketing plays an important role in forming service perceptions and attitudes concerning medication efficiency and devotion. This paper examines the influence of consumer biases and heuristics on efficiency beliefs and medication devotion in the context of pharmaceutical marketing game plans. Drawing on subjective theories of accountability, concerned with the manner of behaving economics, and marketing research, this study synthesizes existent evidence to illuminate by what method intelligent biases and heuristics impact service attitudes and demeanor towards drug products. The study labels several key biases and heuristics prevailing in pharmaceutical marketing, including holding, chance heuristics, ratification bias, and friendly proof. These biases frequently lead users to exaggerate medication productivity through limited news, informal evidence, or persuasive shopping ideas. Consequently, buyers may exhibit taller beliefs of medication influence than authorized, potentially superior to non-devotion or dissatisfaction accompanying situational effects. Moreover, pharmaceutical marketing tactics, such as celebrity endorsements, emotional appeals, and framing effects, exploit these biases to influence consumer perceptions and drive sales. However, while these strategies may initially boost medication uptake, they can also contribute to unrealistic efficacy expectations and suboptimal adherence in the long term. Understanding the interaction between consumer biases, heuristics, and pharmaceutical marketing is critical for developing interventions to advance informed accountability and enhance medication devotion. By combining concern with manner of behaving insights into marketing campaigns and patient instruction initiatives, shareholders can diminish the impact of biases, enhance cure education, and promote more rational cure-connected decision-making between customers.
Onychomycosis is a long-term fungal infection (usually not painful) of the nails and fingernails. It can affect the quality of life of a patient by interfering with their footwear. It can affect as many as 30% of people by the age of 60. In over 99% of the cases, dermatophytes are the cause of the infection. The most common types of dermatophytes in onychomycosis are the rubrum fungus and the mentophyte fungus. Each of these four clinical types (as defined by the way the fungal invasion occurs) has a distinctive appearance, although other diseases (especially psoriasis) may also have a distinctive appearance. Pharmacological treatment has been poor in the past. The first FDA-approved oral agent, Griseofulvin, must be dosed for at least one year to be effective. Low cure rates are linked to poor bioavailability and the drug is fungistatic rather than fungicidal. Newer agents promise to dramatically increase cure rates while decreasing treatment durations. Appropriate management includes confirmation fungal infections (PKG slides) and culture. Oral terbinofine is potent fungicide against dermatophyte and has been shown to be effective with short dosing regimens up to 12 weeks when nail involvement is not 100%.
